CARULLI, Nicola
 Distribuzione geografica
Continente #
NA - Nord America 14.617
EU - Europa 8.534
AS - Asia 7.133
SA - Sud America 838
AF - Africa 144
Continente sconosciuto - Info sul continente non disponibili 80
OC - Oceania 16
Totale 31.362
Nazione #
US - Stati Uniti d'America 14.404
SE - Svezia 2.337
SG - Singapore 2.225
CN - Cina 2.080
IT - Italia 1.999
GB - Regno Unito 1.833
HK - Hong Kong 827
DE - Germania 656
BR - Brasile 610
VN - Vietnam 610
FI - Finlandia 377
UA - Ucraina 332
BD - Bangladesh 326
TR - Turchia 318
FR - Francia 305
RU - Federazione Russa 242
KR - Corea 198
IN - India 141
BG - Bulgaria 125
CA - Canada 100
AR - Argentina 88
NL - Olanda 69
ID - Indonesia 55
MX - Messico 55
IQ - Iraq 52
JP - Giappone 47
ZA - Sudafrica 38
IE - Irlanda 35
AE - Emirati Arabi Uniti 34
CH - Svizzera 30
PL - Polonia 30
VE - Venezuela 30
CO - Colombia 27
EC - Ecuador 27
TW - Taiwan 27
ES - Italia 26
MY - Malesia 24
BE - Belgio 23
CZ - Repubblica Ceca 23
PK - Pakistan 21
CL - Cile 20
MA - Marocco 19
PH - Filippine 19
UZ - Uzbekistan 19
AT - Austria 15
CR - Costa Rica 15
EG - Egitto 14
KE - Kenya 14
SA - Arabia Saudita 14
PT - Portogallo 13
AU - Australia 11
JO - Giordania 11
PE - Perù 11
PY - Paraguay 11
AZ - Azerbaigian 10
NP - Nepal 10
DO - Repubblica Dominicana 9
DZ - Algeria 9
IL - Israele 9
IR - Iran 9
RO - Romania 9
SC - Seychelles 9
BO - Bolivia 8
EU - Europa 8
ET - Etiopia 7
LT - Lituania 7
TN - Tunisia 7
NG - Nigeria 6
NI - Nicaragua 6
OM - Oman 6
PA - Panama 6
SI - Slovenia 6
BH - Bahrain 5
LU - Lussemburgo 5
TH - Thailandia 5
UY - Uruguay 5
AL - Albania 4
GE - Georgia 4
HN - Honduras 4
HU - Ungheria 4
KG - Kirghizistan 4
KZ - Kazakistan 4
NZ - Nuova Zelanda 4
RS - Serbia 4
SK - Slovacchia (Repubblica Slovacca) 4
SN - Senegal 4
UG - Uganda 4
AM - Armenia 3
AO - Angola 3
BB - Barbados 3
BY - Bielorussia 3
GR - Grecia 3
HR - Croazia 3
JM - Giamaica 3
KW - Kuwait 3
LB - Libano 3
LV - Lettonia 3
MK - Macedonia 3
SV - El Salvador 3
TT - Trinidad e Tobago 3
Totale 31.256
Città #
Stockholm 1.787
Singapore 1.505
Santa Clara 1.304
Ashburn 1.188
Southend 1.147
Fairfield 1.030
Hong Kong 812
Woodbridge 790
Jacksonville 726
Chandler 721
Hefei 689
San Jose 661
Houston 622
Dearborn 492
Ann Arbor 469
Chicago 380
Seattle 380
Wilmington 377
Beijing 374
Cambridge 361
Nyköping 346
Los Angeles 336
London 300
Council Bluffs 270
Helsinki 229
The Dalles 210
Ho Chi Minh City 189
Seoul 185
Izmir 182
New York 182
Milan 180
Hanoi 158
Salt Lake City 144
Princeton 128
Modena 125
San Diego 123
Sofia 120
Eugene 115
Rome 113
Des Moines 111
Munich 103
Shanghai 98
Lauterbourg 96
Buffalo 93
Boardman 92
Tampa 87
Columbus 74
Dallas 73
Grafing 73
Elk Grove Village 71
Moscow 69
São Paulo 61
Bologna 54
Orem 50
Bremen 48
Falls Church 46
Naples 39
Sterling 37
Turin 36
Guangzhou 33
Bari 32
Dublin 32
Tokyo 31
Turku 30
Baghdad 29
Kunming 29
Palermo 28
Brooklyn 27
Florence 27
Lancaster 27
Napoli 27
Frankfurt am Main 26
Chennai 25
Da Nang 25
Kent 25
Phoenix 25
Redwood City 25
Mexico City 24
Warsaw 24
Miami 23
Jakarta 22
Montreal 22
Torino 22
Atlanta 21
Haiphong 21
Brussels 20
San Mateo 20
Brno 19
Catania 19
Nanjing 19
Toronto 19
Amsterdam 18
North Bergen 18
Rio de Janeiro 18
Verona 18
Parma 17
Falkenstein 16
San Francisco 16
Sondrio 16
Zhengzhou 16
Totale 21.812
Nome #
"Assay of HMG-CoA reductase activity in the evaluation of cholesterol synthesis in man". 2.052
Le basi scientifiche dell'approccio bio-psico-sociale. Indicazioni per l'acquisizione delle competenze mediche appropriate 1.686
Increased appearance rate of 27-hydroxycholesterol in vivo in hypercholesterolemia: A possible compensatory mechanism. 461
Differential effect of oleic and palmitic acid on lipid accumulation and apoptosis in cultured hepatocytes 444
Effect of liver cirrhosis on the systemic availability of naltrexone in humans 439
Age-related changes in bile acid synthesis and hepatic nuclear receptor expression 435
Review article: diabetes, genetics and ethnicity 419
Changes in bile acid synthesis in gallstone disease: cause, consequence or neither? 413
Decreased hepatic expression of PPAR-gamma coactivator-1 in cholesterol cholelithiasis. 413
Review article: the metabolic syndrome and non-alcoholic fatty liver disease 390
Characteristics of patients in a ward of Academic Internal Medicine. Implications for medical care, training programs and research 367
Herpesvirus DNA is frequently detected in liver tissue from hepatitis C patients 356
Correlation between plasma levels of 7alpha-hydroxy-4-cholesten-3-one and cholesterol 7alpha-hydroxylation rates in vivo in hyperlipidemic patients 348
Effects of bile duct ligation and cholic acid treatment on fatty liver in two rat models of non-alcoholic fatty liver disease 346
Growth of human herpesvirus 6 in HepG2 cells 331
In Vivo Degradation of Cholesterol to Bile Acids Is Reduced in Patients Receiving Parenteral Nutrition. 331
Genetic polymorphisms in non-alcoholic fatty liver disease: Interleukin-6-174G/C polymorphism is associated with non-alcoholic steatohepatitis 326
Comparative cytotoxic and cytoprotective effects of taurohyodeoxycholic acid (THDCA) and tauroursodeoxycholic acid (TUDCA) in HepG2 cell line. 319
Factors associated with gallstone disease in the MICOL experience 315
Liver and kidney foreign bodies granulomatosis in a patient with malocclusion, bruxism, and worn dental prostheses 314
Nuclear receptors as potential molecular targets in cholesterol accumulation conditions: Insights from evidence on hepatic cholesterol degradation and gallstone disease in humans 312
Regulation of bile acid synthesis in humans: effect of treatment with bile acids, cholestyramine or simvastatin on cholesterol 7 alpha-hydroxylation rates in vivo. 311
'Endocrine NAFLD' a hormonocentric perspective of nonalcoholic fatty liver disease pathogenesis 301
Epidemiology of gallstone disease in Italy: prevalence data of the Multicenter Italian Study on Cholelithiasis (M.I.COL.) 299
INCREASED 27-HYDROXYLATION OF CHOLESTEROL IN PRIMARY HYPERCHOLESTEROLEMIA 299
Advances in the comprehension of the pathophysiology of bile secretion 292
Chicken or egg turned into head or belly 291
Effects of acute changes of bile acid pool composition on biliary lipid secretion 288
Risk for cardiovascular events in an Italian population of patients with type 2 diabetes 285
Hepatic nuclear receptors in human cholelithiasis: A link with insulin resistance? 285
Alpha but not beta interferon is useful in chronic active hepatitis due to hepatitis C virus - A prospective, double-blind, randomized study 284
Non-alcoholic fatty liver disease (NAFLD) and cardiovascular disease: An open question 282
Fasting insulin and uric acid levels but not indices of iron metabolism are independent predictors of non-alcoholic fatty liver disease. A case-control study 279
Bile acid feeding and hepatic sterol metabolism: effect of deoxycholic acid. 278
Bile acid structure and regulation of biliary protein secretion and composition in man 276
Effect of ursocholic acid on bile lipid secretion and composition 275
Determinants of bile secretion: effect of bile salt structure on bile flow and biliary cation secretion 275
NAFLD AND TYPE 2 DIABETES: A GENETIC OR METABOLIC ISSUE? 272
ESTIMATION OF CARDIOVASCULAR RISK IN TYPE 2 DIABETES 269
Effect of taurohyodeoxycholic acid on biliary lipid secretion in humans 268
MOLECULAR REGULATION OF STEROL METABOLISM BY BILE ACIDS IN CULTURED HUMAN HEPATOCYTES 266
Review article: hyperlipidaemia and cardiovascular risk 264
Growth hormone plasma levels in nonalcoholic fatty liver disease 256
Influence of age and sex on serum concentrations of total dimeric activin A 253
Intestinal solubilization, absorption, pharmacokinetics and bioavailability of chenodeoxycholic acid. 251
Steatosis and hepatitis C virus: mechanisms and significance for hepatic and extrahepatic disease 250
Influence of age on bile acid synthesis: Role of hepatic expression of nuclear receptors 250
Effect of diabetic autonomic neuropathy on gallbladder kinetics in insulin dependent diabetic patients 246
Cholesterol metabolism in gallstone disease .Preliminary evidence from the analysis of circulating markers of sterol homeostasis 242
Effect of small doses of deoxycholic acid on bile cholesterol saturation in patients with liver cirrhosis 240
HEPATIC EXPRESSION OF NUCLEAR RECEPTORS AND BILIARY TRANSPOTERS IN HUMAN CHOLESTEROL GALLSTONE DISEASE. 240
Fecal neutral steroids in normal conditions and in patients with polyps or cancer of the large bowel 239
HEPATIC NUCLEAR RECEPTOR EXPRESSION AND REGULATION OF BILE ACID SYNTHESIS IN HUMANS 237
BILE CHANGES DURING TREATMENT WITH DEOXYCHOLIC-ACID - REPLY 236
In vivo evaluation of cholesterol 7 alpha-hydroxylation in humans: effect of disease and drug treatment 235
HCV and diabetes. A two-question-based reappraisal. 229
Bile acid and hepatocyte death 229
Regolazione della sintesi di colesterolo e acidi biliari 228
Effects of different phenotypes of hyperlipoproteinemia and of treatment with fibric acid derivatives on the rates of cholesterol 7alpha-hydroxylation in humans 225
RISK FOR CARDIOVASCULAR EVENTS IN AN ITALIAN POPULATION OF PATIENTS WITH TYPE 2 DIABETES 224
Effect of aging on cholesterol 7 alpha-hydroxylation in humans 223
Olanzapine-induced hypertriglyceridemia and Diabetes mellitus 223
Dysmetabolic changes associated with HCV: a distinct syndrome? 221
Fatty liver, carotid disease and gallstones: A study ofage-related associations 219
Statins and HCV: a complex issue 218
Nuclear receptors and obstructive cholestasis in Humans: increased heaptic expression of short heterodimer partner : a protective response? 214
Effect of acute administration of bile acids on fatty acid composition of biliary phosphatidylcholine in man 209
TYPE 2 DIABETES AND CARDIOVASCULAR EVENTS : STUDY OF THE AMIN RISK FACTORS IN A LOCAL POPULATION OF PATIENTS 207
EFFECT OF FISH OIL AND COCONUT OIL DIET ON THE LDL RECEPTOR ACTIVITY OF RAT LIVER PLASMA MEMBRANES. 206
Cirrosi criptogenetiche. Un report di 5 pazienti 206
NAFLD AND TYPE 2 DIABETES: A GENETIC OR METABOLIC ISSUE? 201
Prevalence rates of gallstone disease in Italy: the Chianciano population study 201
Concurrent non-alcoholic steatohepatitis and psoriasis. Report of three cases from the POLI.ST.E.N.A. study. 201
Complications following percutaneous liver biopsy: a multicenter retrospective study on 68.276 biopsies 201
The prevalence of autoantibodies and autoimmune hepatitis in patients with nonalcoholic fatty liver disease 200
HEPATIC NUCLEAR RECEPTOR EXPRESSION AND REGULATION OF BILE ACID SYNTHESIS IN HUMANS 200
EFFECT OF CHENODEOXYCHOLIC ACID AND URSODEOXYCHOLIC ACID ADMINISTRATION ON ACYL-COA - CHOLESTEROL ACYLTRANSFERASE ACTIVITY IN HUMAN LIVER 199
Hepatitis C and steatosis: a reappraisal 198
Reply 198
Acute abdomen associated with schistosomiasis of the appendix 193
Regulation of bile acid synthesis in humans: studies on cholesterol 7alpha-hydroxylation 'in vivo' 192
Cholestatic icterus: is there still a role for the clinic? 191
Chronic hepatopathies: from cryptogenetics to multiple factors 190
Patogenesi della colelitiasi 190
Ursodeoxycholic acid improves liver tests in chronic hepatitis - Results of a randomised controlled trial 189
Effect of taurohyodeoxycholic acid on biliary lipid secretion in man: preliminary report. 187
Colelitiasi sintomatica: affiorano dubbi sulla necessita' dell'intervento. 186
Risk for cardiovascular events in a local population of diabetic patients 183
Patogenesi ed epidemiologia della steatosi epatica e della steatoepatite non alcolica (NASH). 179
Effects of bile acid pool composition on hepatic metabolism of cholesterol in man 179
Should nonalcoholic fatty liver disease be renamed? 178
Nuove prospettive terapeutiche con acidi biliari. 175
Structure and concentartion of differenty fatty acid (FFAS) affect steatosis extent and apoptosis in hepatocytes coltures 174
RISK FOR CARDIOVASCULAR EVENTS IN A LOCAL POPULATION OF DIABETIC PATIENTS 173
Tipologia dei ricoveri negli Ospedali Universitari: l'impatto sulle attività istituzionali 170
Gallstone dissolution. 170
DIABETES AND CARDIOVASCULAR EVENTS: USEFULNESS AND LIMITS OF RISK FUNCTIONS 166
Bile acids and cholesterol metabolism: Effect of deoxycholic acid on plasma lipoprotein and biliary cholesterol concentration 165
Dietary cholesterol absorption in cirrhosis: the role of total and individual bile acid pool size. 164
Dislipidemie.In Teodori 2004. Trattato italiano di medicina interna 162
Totale 28.767
Categoria #
all - tutte 114.658
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 114.658


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.813 0 0 194 200 54 114 155 118 229 125 365 259
2022/20232.135 235 218 135 210 241 379 59 185 270 31 89 83
2023/20241.387 72 68 66 108 267 131 182 178 45 49 84 137
2024/20254.750 181 92 104 315 988 599 381 219 442 176 550 703
2025/202611.449 514 441 706 1.119 2.023 735 1.139 377 2.575 804 580 436
2026/2027886 236 587 63 0 0 0 0 0 0 0 0 0
Totale 31.362